Engineering Against the Odds: A New Antibody's Battle with Leukemia - SynBioBeta

Retrieved on: 2024-02-26 18:56:04

Tags for this article:

Cell biology

Biotechnology

CD38

Glycoproteins

Acute myeloid leukemia

Click the tags to see associated articles and topics

Engineering Against the Odds: A New Antibody's Battle with Leukemia - SynBioBeta. View article details on HISWAI: https://www.synbiobeta.com/read/engineering-against-the-odds-a-new-antibodys-battle-with-leukemia

Summary

The City of Hope team's innovation strategy for battling acute myeloid leukemia (AML) involves a CD38-BIONIC antibody that targets CD38-positive leukemia stem cells, offering a potential new treatment that spares healthy cells. Relevant tags include biotechnology, stem cell research, and leukemia.

Article found on: www.synbiobeta.com

View Original Article